Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Alpha Tau Medical Ltd

Alpha Tau Medical Ltd (DRTS) Stock Overview

Explore Alpha Tau Medical Ltd’s financial performance, market position, analyst ratings, and future outlook.

DRTS●NASDAQ
HealthcareMedical - Equipment & Services
$13.14
$0.15(1.15%)
U.S. Market opens in 49h 51m

Alpha Tau Medical Ltd (DRTS)

Meyka AI Score

Z

Key Financials

Market Cap1.2B
P/E Ratio-19.70
EPS (TTM)$-0.67
ROE-0.73%
Fundamental Analysis

AI Price Forecasts

1 Month$12.86
3 Months$15.78
1 Year Target$11.90

DRTS Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Alpha Tau Medical Ltd (NASDAQ: DRTS) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Alpha Tau Medical Ltd's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of DRTS on the NASDAQ shows an RSI of 58.23, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $11.90 for the NASDAQ listing.

Key metrics behind Alpha Tau Medical Ltd's NASDAQ-traded stock include a P/E ratio of -19.70 and a market capitalization of 1.2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of DRTS on the NASDAQ.

Price Performance (NASDAQ: DRTS)

1-Day Change
1.15%
5-Day Change
9.96%
1-Month Change
2.98%
3-Month Change
67.39%
6-Month Change
84.81%
Year-to-Date (YTD) Change
165.45%
1-Year Change
301.83%
3-Year Change
249.47%
5-Year Change
33.54%
All-Time (Max) Change
30.10%

Contact Information

https://www.alphatau.com
972 3 577 4115
Kiryat HaMada St. 5, Jerusalem, JM, 9777605

Company Facts

1,210 Employees
IPO DateMar 8, 2021
CountryIL
Actively Trading

Frequently Asked Questions